The Fifth Circuit Court of Appeals has temporarily reinstated a requirement that abortion pills, specifically mifepristone, must be obtained in person rather than by mail or telemedicine.This decision significantly limits access to the abortion pill in states where abortion is banned.The ruling stems from a lawsuit filed by the state of Louisiana and pauses a 2023 Food and Drug Administration (FDA) regulation that allowed doctors to send mifepristone without an in-person consultation.The court stated that the FDA's previous action undermined Louisiana's policy that every unborn child is a legal person from conception.Mifepristone is the first of a two-pill regimen recommended... [Continue Reading]